ALDH1A1 and Parkinson disease: In PD, there is evidence of inhibition of ALDH in residual DA terminals, resulting in accumulation of DOPAL [54] and ALDH1A1 being substantially decreased in the SN of PD patients, while mitochondrial ALDH2 is increased in the putamen [55].